-Hobyung Chung Researcher Activity Profile

Research Author Detailed Information 

Hobyung Chung Publication Rate By Year

Hobyung Chung has published 2 paper(s) in 2003, 3 paper(s) in 2004, 2 paper(s) in 2006, 14 paper(s) in 2007, 2 paper(s) in 2008, for a total of 23 research publications in total.

Hobyung H Chung Author Information

LAST NAME: chung

FIRST NAME: hobyung

INITIALS: H

AFFILIATION:

Papers

Hobyung Chung's Publication Record

1. A proposal of the modified liver damage classification for hepatocellular carcinoma. Year Published: 2006
Departments of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama 589-8511, Japan.
2. Regulatory failure of serum prohepcidin levels in patients with hepatitis C. Year Published: 2006
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-sayama, Osaka 589-8511, Japan.
3. Review of current staging systems for hepatocellular carcinoma. Year Published: 2007
Departments of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
4. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation. Year Published: 2007
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kinki University School of Medicine, Ohno-Higashi, Osaka-Sayama, Japan.
5. Case of rapidly progressed sarcomatoid hepatocellular carcinoma in a young female without risk factor. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan.
6. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography? Year Published: 2007
Department of Ultrasound, Wuhan General Hospital of the Guangzhou Military Area, Wuhan, PR China.
7. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
8. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Year Published: 2007
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
9. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan. m-kudo@med.kindai.ac.jp
10. Case of rapidly progressed sarcomatoid hepatocellular carcinoma in a young female without risk factor. Year Published: 2007
11. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography? Year Published: 2007
Department of Ultrasound, Wuhan General Hospital of the Guangzhou Military Area, Wuhan, PR China.
12. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
13. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Year Published: 2007
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
14. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study. Year Published: 2007
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan. m-kudo@med.kindai.ac.jp
15. Case of rapidly progressed sarcomatoid hepatocellular carcinoma in a young female without risk factor. Year Published: 2007
16. Foreign body granuloma mimicking disseminated tumour recurrence after radiofrequency ablation for hepatocellular carcinoma. Year Published: 2008
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
17. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. Year Published: 2003
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Japan.
18. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. Year Published: 2003
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan.
19. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. Year Published: 2004
Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan.
20. Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. Year Published: 2004
Department of Internal Medicine, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama 589-8511, Japan.
21. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. Year Published: 2004
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama 589-8511, Japan.
22. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. Year Published: 2007
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayma, Osaka 589-8511, Japan. minkun@med.kindai.ac.jp
23. Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score. Year Published: 2008
Department of Gastroenterology, Kinki University School of Medicine, Osaka-Sayama, Japan.